Amphotericin B and fluconazole susceptibilities of 13 Cryptococcus neoformans isolates from five patients with recurrent cryptococcal meningitis were determined. For each patient, serial isolates showed no increase in antibiotic resistance relative to the initial isolate. For these patients, recurrent disease was not due to drug resistance but may reflect changes in immune function and/or poor compliance.
Cryptococcus neofornans is a yeastlike fungus which causes a progressive meningoencephalitis in 5 to 13% of all patients with AIDS (5, 9, 25) . In the setting of AIDS, cryptococcal meningitis is incurable and lifelong suppression with antifungal agents is necessary to decrease the likelihood of recurrence (5, 9, 25, 26) . In recent years, fluconazole has become widely used for suppression therapy (14, 24) . However, a small number of patients relapse despite fluconazole suppression. We have shown that in recurrent cryptococcal meningitis the initial and relapse isolates are clonally related and hence recurrences result from persistence of the original strain and not from infection with a new strain (21) .
To determine whether recurrences of cryptococcal meningitis are due to drug resistance, we measured the amphotericin B and fluconazole susceptibilities of 13 C. neoformans isolates from 5 patients with recurrent cryptococcal meningitis. All isolates were recovered from cerebrospinal fluid and were identified as C. neoformans var. neoformans on the basis of growth on CGB agar (10) . Patients J9, Jll, and J22 were seen at the Bronx Municipal Hospital Center (Jacobi Hospital, Bronx, N.Y.), and patients SB4 and SB6 were seen at University Hospital at Stony Brook, N.Y. For each patient the A strain is the initial isolate and subsequent letters denote the relapse isolates. In all patients the initial isolates were obtained when the diagnosis was made and before antifungal therapy was begun. The initial and relapse isolates of patients J9, Jil, SB4, and SB6 have been shown to be clonally related by URA5 and CNRE-1 restriction fragment length polymorphism analysis and electrophoretic karyotyping of intact chromosomes (21) . The J22 isolates were studied only by restriction fragment length polymorphism analysis of polymerase chain reaction-amplified URAS sequences (4) which revealed no differences between J22A and J22B. Four patients had AIDS (J9, J22, SB4, and SB6), and one (Jil) had a chronic lymphocytic leukemia and negative serology for human immunodeficiency virus. Figure  1 Recent studies on the development of standardized antifungal susceptibility assays have specifically noted difficulties with C. neofonnans susceptibility testing (6, 8, 13 serum for these drugs (1, 3, 16) . For the four AIDS patients on fluconazole suppression (J9, J22, SB4, and SB6) the MICs and MLCs for the relapse isolates were the same as or lower than those for the initial isolates at 24 h. Thus, the MIC data from our isolates provide strong evidence against fluconazole resistance being the cause of recurrent cryptococcal meningitis. Surprisingly, the MICs of fluconazole for J9 isolates exhibited a decrease despite long-term therapy with this drug. Although the basis for this increased susceptibility is not known, the MIC results for the J9 strains are consistent with the long asymptomatic period experienced by this patient following recurrence of his meningitis and treatment with amphotericin B.
There has been one well-documented case of amphotericin B-resistant C. neoformans in a patient with AIDS (15) . Amphotericin B is a polyene antibiotic which mediates antifungal effects by binding to cell membrane sterols, damaging the cell membrane and resulting in leakage of essential metabolites (3). Fluconazole is a triazole which inhibits membrane sterol synthesis (18) . Since azoles block the synthesis of ergosterol, the target of amphotericin B, there has been concern about.using these two types of antifungal agents together (2, 19, 20, 22, 23) . C. albicans (23) and Aspergillus fumigatus (20) have been reported to become resistant to amphotericin B in the presence of ketoconazole (23) . In this regard it is noteworthy that chronic fluconazole suppression in our patient group did not increase C. neoformans resistance to amphotericin B.
The potential development of fluconazole resistance is a serious concern, given the widespread use of fluconazole suppression therapy. Our data indicate that fluconazole MICs can vary widely among isolates; therefore, it is essential to test paired isolates from the same patient when investigating relapses of cryptococcal meningitis. Where there is an increase in MIC, it is important to type strains to distinguish between selection for resistant mutants versus the acquisition of new resistant strains. This is now possible for many fungi, including C. neoformans, given the development of molecular probes for genetic typing.
Recurrent cryptococcal meningitis results from persistence of the initial infection despite antifungal therapy (21 
